Role of Flexible Bronchoscopy in Lung Transplantation

Prashant N. Chhajed; Michael Tamm; Allan R. Glanville

doi:10.1055/s-2004-832714

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2004; 25(4): 413-423
DOI: 10.1055/s-2004-832714

Role of Flexible Bronchoscopy in Lung Transplantation

Prashant N. Chhajed¹ ^, ² ^, ³ , Michael Tamm¹ ^, ³ , Allan R. Glanville²

¹Division of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland
²The Lung Transplant Unit, St. Vincent’s Hospital, Sydney, Australia
³Institute of Pulmonology, Medical Research and Development, Mumbai, India

Abstract

Flexible bronchoscopy with bronchoalveolar lavage and transbronchial biopsy has contributed significantly to the success of lung transplantation to detect rejection and infections (bacterial, fungal, viral, and protozoal). It permits the visualization of the airway anastomosis and also allows for the management of airway complications using interventional bronchoscopic techniques such as balloon dilatation, stent insertion, and laser. A new classification (TEGLA [thickness, extent of injury, granulation tissue, loose sutures, anastomotic complications]) for uniform reporting of airway ischemic injury is proposed. The common complications during flexible bronchoscopy include acute hypoxemia, bleeding, and pneumothorax. The management of these complications during flexible bronchoscopy and the value of surveillance and follow-up transbronchial biopsy and bronchoalveolar lavage is discussed. Bronchoalveolar lavage and transbronchial biopsy are also used for research purposes and might hopefully allow recognition of bronchiolitis obliterans at an earlier stage.

KEYWORDS

Flexible bronchoscopy - lung transplantation - transbronchial biopsy - bronchoalveolar lavage - stent

Full Text

References

REFERENCES

1 Baldwin J C, Oyer P E, Stinson E B et al.. Comparison of cardiac rejection in heart and heart-lung transplantation. J Heart Transplant. 1987; 6 352-356
2 Rhenman B, Rhenman M J, Icenogle T B et al.. Heart-lung transplantation: the initial Arizona experience. J Thorac Cardiovasc Surg. 1989; 98(5 Pt 2) 922-927
3 Glanville A R, Imoto E, Baldwin J C et al.. The role of right ventricular endomyocardial biopsy in the long-term management of heart-lung transplant recipients. J Heart Transplant. 1987; 6 357-361
4 Higenbottam T, Hutter J A, Stewart S, Wallwork J. Transbronchial biopsy has eliminated the need for endomyocardial biopsy in heart-lung recipients. J Heart Transplant. 1988; 7 435-439
5 Husain A N, Siddiqui M T, Montoya A, Chandrasekhar A J, Garrity E R. Post-lung transplant biopsies: an 8-year Loyola experience. Mod Pathol. 1996; 9 126-132
6 Higenbottam T, Stewart S, Penketh A, Wallwork J. Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation. 1988; 46 532-539
7 Yousem S A, Berry G J, Cagle P T et al.. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant. 1996; 15(1 Pt 1) 1-15
8 Trulock E P, Ettinger N A, Brunt E M et al.. The role of transbronchial lung biopsy in the treatment of lung transplant recipients: an analysis of 200 consecutive procedures. Chest. 1992; 102 1049-1054
9 Sibley R K, Berry G J, Tazelaar H D et al.. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant. 1993; 12 308-324
10 Hopkins P M, Aboyoun C L, Chhajed P N et al.. Prospective analysis of 1,235 transbronchial lung biopsies in lung transplant recipients. J Heart Lung Transplant. 2002; 21 1062-1067
11 British Thoracic Society guidelines on diagnostic flexible bronchoscopy. Thorax. 2001; 56(Suppl 1) i1-21
12 Pearce S J. Fibreoptic bronchoscopy: is sedation necessary?. BMJ. 1980; 281 779-780
13 Colt H G, Morris J F. Fiberoptic bronchoscopy without premedication: a retrospective study. Chest. 1990; 98 1327-1330
14 Simpson F G, Arnold A G, Purvis A et al.. Postal survey of bronchoscopic practice by physicians in the United Kingdom. Thorax. 1986; 41 311-317
15 Prakash U B, Offord K P, Stubbs S E. Bronchoscopy in North America: the ACCP survey. Chest. 1991; 100 1668-1675
16 Reed A P. Preparation of the patient for awake flexible fiberoptic bronchoscopy. Chest. 1992; 101 244-253
17 Rees P J, Hay J G, Webb J R. Premedication for fibreoptic bronchoscopy. Thorax. 1983; 38 624-627
18 Macfarlane J T, Storr A, Wart M J, Smith W H. Safety, usefulness and acceptability of fibreoptic bronchoscopy in the elderly. Age Ageing. 1981; 10 127-131
19 Williams T J, Nicoulet I, Coleman E, McAlaney C. Safety and patient acceptability of intravenous midazolam for fibre optic bronchoscopy. Respir Med. 1994; 88 305-307
20 Chhajed P N, Aboyoun C L, Malouf M A et al.. Progressive increase in sedative drug requirements for flexible bronchoscopy in lung transplant recipients. Am J Respir Crit Care Med. 2003; 167 A529
21 Chhajed P N, Cooper P. Pediatric flexible bronchoscopy. Indian Pediatr. 2001; 38 1382-1392
22 Chhajed P N, Aboyoun C, Malouf M A et al.. Management of acute hypoxemia during flexible bronchoscopy with insertion of a nasopharyngeal tube in lung transplant recipients. Chest. 2002; 121 1350-1354
23 Chhajed P N, Tamm M, Malouf M A, Glanville A R. Lung transplantation: management and complications. Indian J Chest Dis Allied Sci. 2002; 44 31-43
24 Snell G I, Ward C, Wilson J W et al.. Immunopathological changes in the airways of stable lung transplant recipients. Thorax. 1997; 52 322-328
25 Heurlin N, Markling L, Barkholt L et al.. Rapid detection of cytomegalovirus antigen on alveolar cells in bronchoalveolar fluid from transplant patients with cytomegalovirus pneumonia. Clin Transplant. 1994; 8 466-473
26 Tiroke A H, Bewig B, Haverich A. Bronchoalveolar lavage in lung transplantation: state of the art. Clin Transplant. 1999; 13 131-157
27 Zavala D C. Pulmonary hemorrhage in fiberoptic transbronchial biopsy. Chest. 1976; 70 584-588
28 Chhajed P N, Aboyoun C, Malouf M A et al.. Risk factors and management of bleeding associated with transbronchial lung biopsy in lung transplant recipients. J Heart Lung Transplant. 2003; 22 195-197
29 Scott J P, Fradet G, Smyth R L et al.. Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Lung Transplant. 1991 10(5 Pt 1): 626-636 discussion 636-627
30 Chhajed P N, Malouf M A, Glanville A R. Bronchoscopic dilatation in the management of benign (non-transplant) tracheobronchial stenosis. Intern Med J. 2001; 31 512-516
31 Sheski F D, Mathur P N. Long-term results of fiberoptic bronchoscopic balloon dilation in the management of benign tracheobronchial stenosis. Chest. 1998; 114 796-800
32 Davies D G, Parsek M R, Pearson J P et al.. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998; 280 295-298
33 Kolter R, Losick R. One for all and all for one. Science. 1998; 280 226-227
34 Seballos R J, Mehta A C. Care and maintenence of the flexible bronchoscope. In: Wang KMA Flexible Bronchoscopy Boston, MA; Blackwell 1995: 81-92
35 Culver D A, Gordon S M, Mehta A C. Infection control in the bronchoscopy suite: a review of outbreaks and guidelines for prevention. Am J Respir Crit Care Med. 2003; 167 1050-1056
36 Rutala W A, Gergen M F, Weber D J. Comparative evaluation of the sporicidal activity of new low-temperature sterilization technologies: ethylene oxide, 2 plasma sterilization systems, and liquid peracetic acid. Am J Infect Control. 1998; 26 393-398
37 Muscarella L F. Deja vu … all over again? The importance of instrument drying. Infect Control Hosp Epidemiol. 2000; 21 628-629
38 Kirschke D L, Jones T F, Craig A S et al.. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes. N Engl J Med. 2003; 348 214-220
39 Pereira Jr W, Kovnat D M, Snider G L. A prospective cooperative study of complications following flexible fiberoptic bronchoscopy. Chest. 1978; 73 813-816
40 Credle Jr W F, Smiddy J F, Elliott R C. Complications of fiberoptic bronchoscopy. Am Rev Respir Dis. 1974; 109 67-72
41 Langmack E L, Martin R J, Pak J, Kraft M. Serum lidocaine concentrations in asthmatics undergoing research bronchoscopy. Chest. 2000; 117 1055-1060
42 Chhajed P N, Aboyoun C L, Malouf M A et al.. Prophylactic nasopharyngeal tube insertion prevents acute hypoxemia due to upper airway obstruction during flexible bronchoscopy. Intern Med J. 2003; 33(7) 317-318
43 Chhajed P N, Glanville A R. Management of hypoxemia during flexible bronchoscopy. Clin Chest Med. 2003; 24 511-516
44 Diette G B, Wiener C M, White Jr P. The higher risk of bleeding in lung transplant recipients from bronchoscopy is independent of traditional bleeding risks: results of a prospective cohort study. Chest. 1999; 115 397-402
45 Cordasco Jr E M, Mehta A C, Ahmad M. Bronchoscopically induced bleeding: a summary of nine years’ Cleveland clinic experience and review of the literature. Chest. 1991; 100 1141-1147
46 Prakash U B, Utz J P. Bronchoscopic lung biopsy. In: Wang KP, Mehta AC Flexible Bronchoscopy London; Blackwell 1995: 119-135
47 Breuer H W, Charchut S, Worth H, Trampisch H J, Glanzer K. Endobronchial versus intravenous application of the vasopressin derivative glypressin during diagnostic bronchoscopy. Eur Respir J. 1989; 2 225-228
48 Barman S A, Ardell J L, Parker J C, Perry M L, Taylor A E. Pulmonary and systemic blood flow contributions to upper airways in canine lung. Am J Physiol. 1988; 255(5 Pt 2) H1130-H1135
49 Magno M. Comparative anatomy of the tracheobronchial circulation. Eur Respir J Suppl. 1990; 12 557s-562s , discussion 562s-563s
50 Shennib H, Massard G. Airway complications in lung transplantation. Ann Thorac Surg. 1994; 57 506-511
51 Couraud L, Nashef S AM, Nicolini P, Jougon J. Classification of airway anastomotic healing. Eur J Cardiothorac Surg. 1992; 6 496-497
52 Malouf M A, Glanville A R. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med. 1999; 160(5 Pt 1) 1611-1616
53 Tamm M, Malouf M, Glanville A. Pulmonary Scedosporium infection following lung transplantation. Transpl Infect Dis. 2001; 3 189-194
54 Yousem S A. Graft eosinophilia in lung transplantation. Hum Pathol. 1992; 23 1172-1177
55 Nunley D R, Grgurich W, Iacono A T et al.. Allograft colonization and infections with Pseudomonas in cystic fibrosis lung transplant recipients. Chest. 1998; 113 1235-1243
56 Kramer M R, Stoehr C, Lewiston N J, Starnes V A, Theodore J. Trimethoprim-sulfamethoxazole prophylaxis for Pneumocystis carinii infections in heart-lung and lung transplantation: how effective and for how long?. Transplantation. 1992; 53 586-589
57 Miller R F, Le Noury J, Corbett E L, Felton J M, De Cock K M. Pneumocystis carinii infection: current treatment and prevention. J Antimicrob Chemother. 1996; 37(suppl B) 33-53
58 Cahill B C, Hibbs J R, Savik K et al.. Aspergillus airway colonization and invasive disease after lung transplantation. Chest. 1997; 112 1160-1164
59 Nunley D R, Ohori P, Grgurich W F et al.. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest. 1998; 114 1321-1329
60 Helmi M, Love R B, Welter D, Cornwell R D, Meyer K C. Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. Chest. 2003; 123 800-808
61 Stephan F, Bernaudin J F, Cesari D et al.. Blood and alveolar lymphocyte subsets in pulmonary cytomegalovirus infection after lung transplantation. BMC Infect Dis. 2001; 1 15
62 Riise G C, Kjellstrom C, Ryd W et al.. Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study. Eur Respir J. 1997; 10 1742-1746
63 Bewig B, Haacke T C, Tiroke A et al.. Detection of CMV pneumonitis after lung transplantation using PCR of DNA from bronchoalveolar lavage cells. Respiration. 2000; 67 166-172
64 Boehler A, Vogt P, Zollinger A, Weder W, Speich R. Prospective study of the value of transbronchial lung biopsy after lung transplantation. Eur Respir J. 1996; 9 658-662
65 Kesten S, Chamberlain D, Maurer J. Yield of surveillance transbronchial biopsies performed beyond two years after lung transplantation. J Heart Lung Transplant. 1996; 15 384-388
66 Valentine V G, Taylor D E, Dhillon G S et al.. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant. 2002; 21 319-326
67 Tamm M, Sharples L D, Higenbottam T W, Stewart S, Wallwork J. Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies. Am J Respir Crit Care Med. 1997; 155 1705-1710
68 Baz M A, Layish D T, Govert J A et al.. Diagnostic yield of bronchoscopies after isolated lung transplantation. Chest. 1996; 110 84-88
69 Aboyoun C L, Tamm M, Chhajed P N et al.. Diagnostic value of follow-up transbronchial lung biopsy after lung rejection. Am J Respir Crit Care Med. 2001; 164 460-463
70 Pomerance A, Madden B, Burke M M, Yacoub M H. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations. J Heart Lung Transplant. 1995; 14 761-773
71 Chamberlain D, Maurer J, Chaparro C, Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant. 1994; 13 963-971
72 Collins J, Hartman M J, Warner T F et al.. Frequency and CT findings of recurrent disease after lung transplantation. Radiology. 2001; 219 503-509
73 Gabbay E, Dark J H, Ashcroft T et al.. Recurrence of Langerhans' cell granulomatosis following lung transplantation. Thorax. 1998; 53 326-327
74 Habib S B, Congleton J, Carr D et al.. Recurrence of recipient Langerhans’ cell histiocytosis following bilateral lung transplantation. Thorax. 1998; 53 323-325
75 Chhajed P N, Malouf M A, Tamm M, Spratt P, Glanville A R. Interventional bronchoscopy for the management of airway complications following lung transplantation. Chest. 2001; 120 1894-1899
76 Griffith B P, Hardesty R L, Armitage J M et al.. A decade of lung transplantation. Ann Surg. 1993; 218 310-318 , discussion 318-320
77 Schafers H J, Haydock D A, Cooper J D. The prevalence and management of bronchial anastomotic complications in lung transplantation. J Thorac Cardiovasc Surg. 1991; 101 1044-1052
78 Schmid R A, Boehler A, Speich R et al.. Bronchial anastomotic complications following lung transplantation: still a major cause of morbidity. Eur Respir J. 1997; 10 2872-2875
79 Carre P, Rousseau H, Lombart L et al.. Balloon dilatation and self-expanding metal Wallstent insertion: for management of bronchostenosis following lung transplantation. The Toulouse Lung Transplantation Group. Chest. 1994; 105 343-348
80 Kshettry V R, Kroshus T J, Hertz M I et al.. Early and late airway complications after lung transplantation: incidence and management. Ann Thorac Surg. 1997; 63 1576-1583
81 Brichon P Y, Blanc-Jouvan F, Rousseau H et al.. Endovascular stents for bronchial stenosis after lung transplantation. Transplant Proc. 1992; 24 2656-2659
82 Vinograd I, Klin B, Brosh T et al.. A new intratracheal stent made from nitinol, an alloy with “shape memory effect”. J Thorac Cardiovasc Surg. 1994; 107 1255-1261
83 Williams D F. Titanium as a metal for implantation, II: Biological properties and clinical applications. J Med Eng Technol. 1977; 1 266-270
84 Chhajed P N, Malouf M A, Tamm M, Glanville A R. Ultraflex stents for the management of airway complications in lung transplant recipients. Respirology. 2003; 8 59-64
85 Tamm M, Roth M, Malouf M et al.. Primary fibroblast cell cultures from transbronchial biopsies of lung transplant recipients. Transplantation. 2001; 71 337-339
86 Azzola A, Havryk A, Chhajed P N et al.. Everolimus and mycophenolate mofetil are potent inhibitors of fibroblast proliferation after lung transplantation. Transplantation. 2004; 77 275-280
87 Bergmann M, Tiroke A, Schafer H, Barth J, Haverich A. Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation. Scand Cardiovasc J. 1998; 32 97-103
88 Scholma J, Slebos D J, Boezen H M et al.. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med. 2000; 162 2221-2225
89 Havryk A, Azzola A, Chhajed P N et al.. Matrix metalloproteinase profile in bronchoalveolar lavage fluid in posttransplant obliterative bronchiolitis. Am J Respir Crit Care Med. 2002; 165 A396

Prashant N ChhajedM.D.

Division of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel

Petersgraben 4, CH-4031, Basel, Switzerland

Email: chhajed@hotmail.com